These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 2535957

  • 1. Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.
    Linkhart TA, Mohan S, Jennings JC, Baylink DJ.
    Cancer Res; 1989 Jan 15; 49(2):271-8. PubMed ID: 2535957
    [Abstract] [Full Text] [Related]

  • 2. Parathyroid hormone-related protein and transforming growth factor activities in an extract from a breast cancer associated with humoral hypercalcemia of malignancy.
    Nagata N, Yasutomo Y, Kugai N, Matsuura Y, Akatsu T, Sugiyama K, Kinoshita T, Takatani O, Mamiya Y, Yamaguchi K.
    Jpn J Clin Oncol; 1989 Dec 15; 19(4):353-9. PubMed ID: 2558242
    [Abstract] [Full Text] [Related]

  • 3. In vivo and in vitro biological activities of two human cell lines derived from anaplastic lung cancers.
    Bockman RS, Bellin A, Repo MA, Hickok NJ, Kameya T.
    Cancer Res; 1983 Sep 15; 43(9):4511-6. PubMed ID: 6409406
    [Abstract] [Full Text] [Related]

  • 4. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 5. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA.
    Cancer Res; 1997 Aug 01; 57(15):3194-9. PubMed ID: 9242449
    [Abstract] [Full Text] [Related]

  • 6. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA, Yoneda T, Yates AJ, Mundy GR.
    J Clin Endocrinol Metab; 1993 Jul 01; 77(1):40-5. PubMed ID: 8325957
    [Abstract] [Full Text] [Related]

  • 7. Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: use in culture of primary solid lung tumors.
    Siegfried JM.
    Cancer Res; 1987 Jun 01; 47(11):2903-10. PubMed ID: 3032416
    [Abstract] [Full Text] [Related]

  • 8. Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell line.
    Li X, Drucker DJ.
    Cancer Res; 1993 Jul 01; 53(13):2980-6. PubMed ID: 8319205
    [Abstract] [Full Text] [Related]

  • 9. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
    Sabatini M, Yates AJ, Garrett IR, Chavez J, Dunn JF, Bonewald L, Mundy GR.
    Lab Invest; 1990 Nov 01; 63(5):676-82. PubMed ID: 2232714
    [Abstract] [Full Text] [Related]

  • 10. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
    Salomon DS, Perroteau I, Kidwell WR, Tam J, Derynck R.
    J Cell Physiol; 1987 Mar 01; 130(3):397-409. PubMed ID: 3494020
    [Abstract] [Full Text] [Related]

  • 11. Separation of transforming growth factors TGF alpha and TGF beta during chromatographic purification of extracts from mouse C-234 tumors.
    Popik W.
    Arch Immunol Ther Exp (Warsz); 1987 Mar 01; 35(6):839-51. PubMed ID: 3508041
    [Abstract] [Full Text] [Related]

  • 12. A mouse tumor-derived osteolytic factor stimulates bone resorption by a mechanism involving local prostaglandins production in bone.
    Lau KH, Lee MY, Linkhart TA, Mohan S, Vermeiden J, Liu CC, Baylink DJ.
    Biochim Biophys Acta; 1985 May 29; 840(1):56-68. PubMed ID: 2986710
    [Abstract] [Full Text] [Related]

  • 13. Separation of parathyroid hormone-like activity from transforming growth factor-alpha and -beta in the canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy.
    Merryman JI, Rosol TJ, Brooks CL, Capen CC.
    Endocrinology; 1989 May 29; 124(5):2456-63. PubMed ID: 2539981
    [Abstract] [Full Text] [Related]

  • 14. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
    Yates AJ, Boyce BF, Favarato G, Aufdemorte TB, Marcelli C, Kester MB, Walker R, Langton BC, Bonewald LF, Mundy GR.
    J Bone Miner Res; 1992 Jul 29; 7(7):847-53. PubMed ID: 1642153
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO, Anderson DM, Traianedes K, Williams PJ, Yoneda T, Mundy GR.
    Cancer Res; 2001 Mar 15; 61(6):2572-8. PubMed ID: 11289133
    [Abstract] [Full Text] [Related]

  • 16. Secretion of parathyroid hormone-like activity from human T-cell lymphotropic virus type I-infected lymphocytes.
    Fukumoto S, Matsumoto T, Watanabe T, Takahashi H, Miyoshi I, Ogata E.
    Cancer Res; 1989 Jul 15; 49(14):3849-52. PubMed ID: 2544261
    [Abstract] [Full Text] [Related]

  • 17. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS, Zwiebel JA, Bano M, Losonczy I, Fehnel P, Kidwell WR.
    Cancer Res; 1984 Sep 15; 44(9):4069-77. PubMed ID: 6331663
    [Abstract] [Full Text] [Related]

  • 18. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
    Fernandez-Pol JA, Klos DJ, Grant GA.
    Cancer Res; 1986 Oct 15; 46(10):5153-61. PubMed ID: 3489522
    [Abstract] [Full Text] [Related]

  • 19. A soluble transforming growth factor beta type III receptor suppresses tumorigenicity and metastasis of human breast cancer MDA-MB-231 cells.
    Bandyopadhyay A, Zhu Y, Cibull ML, Bao L, Chen C, Sun L.
    Cancer Res; 1999 Oct 01; 59(19):5041-6. PubMed ID: 10519421
    [Abstract] [Full Text] [Related]

  • 20. Production of bone-resorbing activity and colony-stimulating activity in vivo and in vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis.
    Sato K, Mimura H, Han DC, Kakiuchi T, Ueyama Y, Ohkawa H, Okabe T, Kondo Y, Ohsawa N, Tsushima T.
    J Clin Invest; 1986 Jul 01; 78(1):145-54. PubMed ID: 3487554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.